NCT00002989 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Status UNKNOWN Phase PHASE3
NCT00002980 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Status COMPLETED Phase PHASE1
NCT00002926 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia Status UNKNOWN Phase PHASE3
NCT00002890 Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1
NCT00002833 Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE2
NCT00002832 Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00002809 Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00002800 Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00002790 Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant Status WITHDRAWN Phase PHASE1/PHASE2
NCT00002746 Interleukin-2 in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT00002742 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Status COMPLETED Phase PHASE3
NCT00002718 T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia Status COMPLETED Phase PHASE2
NCT00002547 Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00002517 Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE3
NCT00002504 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Status COMPLETED Phase PHASE2
NCT00002502 Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00001839 A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00001748 HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies Status COMPLETED Phase PHASE1